|
Etoricoxib (brand name Arcoxia®) is a new selective cox-2 inhibitor from Merck & Co. The FDA is requiring additional safety and efficacy data for etoricoxib before it will issue approval. It has been registered in some European countries, e.g. the United Kingdom.
|
